Anzeige
Mehr »
Login
Donnerstag, 03.04.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Warum Almonty Industries zum Schlüsselplayer für NATO-Staaten wird
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3ENW4 | ISIN: US00430H2013 | Ticker-Symbol: 1A80
Frankfurt
03.04.25
15:11 Uhr
0,635 Euro
-0,010
-1,55 %
1-Jahres-Chart
ACCELERATE DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
ACCELERATE DIAGNOSTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,6250,63519:16
0,6250,63519:16

Aktuelle News zur ACCELERATE DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
23.03.Accelerate Diagnostics: Umsatzrückgang trotz Verlustreduktion2
21.03.Accelerate Diagnostics, Inc.: Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance307TUCSON, Ariz., March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today...
► Artikel lesen
ACCELERATE DIAGNOSTICS Aktie jetzt für 0€ handeln
21.03.Accelerate Diagnostics beantragt FDA-Zulassung für WAVE-System2
21.03.Accelerate Diagnostics seeks FDA clearance for WAVE system2
21.03.Accelerate Diagnostics, Inc.: Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results142TUCSON, Ariz., March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today reports financial results for the fourth quarter and year ended...
► Artikel lesen
21.03.Accelerate Diagnostics, Inc - 8-K, Current Report1
21.03.Accelerate Diagnostics reports Q4 results1
10.01.Accelerate Diagnostics reports preliminary FY 2024 revenue of $11.7 million2
10.01.Accelerate Diagnostics, Inc.: Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results230TUCSON, Ariz., Jan. 10, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing...
► Artikel lesen
10.01.Accelerate Diagnostics, Inc - 8-K, Current Report-
04.12.24Hedge Fund and Insider Trading News: George Soros, Ken Griffin, Tiger Management, BlueCrest Capital Management, Pallister Capital, Accelerate Diagnostics Inc (AXDX), CTS Corp (CTS), and More2
07.11.24Accelerate Diagnostics GAAP EPS of -$0.59 misses by $0.12, revenue of $2.98M misses by $0.02M2
07.11.24Accelerate Diagnostics, Inc - 10-Q, Quarterly Report-
07.11.24Accelerate Diagnostics, Inc.: Accelerate Diagnostics Reports Third Quarter 2024 Financial Results92TUCSON, Ariz., Nov. 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter ended September...
► Artikel lesen
07.11.24Accelerate Diagnostics, Inc - 8-K, Current Report-
30.09.24Accelerate Diagnostics, Inc.: Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc System428An automated platform designed to fight against Sepsis and Antimicrobial Resistance (AMR) Enables rapid, automated microbial identification on the Bruker MALDI Biotyper® CA System directly from positive...
► Artikel lesen
08.08.24Accelerate Diagnostics, Inc.: Accelerate Diagnostics Reports Second Quarter 2024 Financial Results195TUCSON, Ariz., Aug. 8, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter ended June 30, 2024. "During the quarter we completed...
► Artikel lesen
08.05.24Accelerate Diagnostics, Inc.: Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results232TUCSON, Ariz., May 8, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial preliminary results for the first quarter ended March 31, 2024. "During the quarter...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1